EP3703669A4
(en )
2021-11-10
Methods of treating cancers
IL283948A
(en )
2021-07-29
Methods for the treatment of depression
SG11201913984RA
(en )
2020-02-27
Methods of treating myelodysplastic syndrome
EP3897642A4
(en )
2022-08-31
Methods of treating inflammation
EP3491129A4
(en )
2020-01-22
Methods of treating osmidrosis
EP3880885A4
(en )
2022-10-05
Surface treatment composition
EP3630184A4
(en )
2021-03-17
Methods for the treatment of chronic pouchitis
EP3856241A4
(en )
2022-10-05
Treatment methods
SG11202102878TA
(en )
2021-04-29
Treatment methods
SG11202105573PA
(en )
2021-06-29
Methods of treating myelodysplastic syndrome
EP3697860A4
(en )
2021-08-25
Surface treatment
EP3448377A4
(en )
2019-12-25
Methods for the treatment of infection
HK40063473A
(en )
2022-06-24
Methods of treating myelodysplastic syndrome
HK40030480A
(en )
2021-02-26
Methods of treating myelodysplastic syndrome
HK40058936A
(en )
2022-04-29
Treatment methods
HK40058935A
(en )
2022-04-29
Treatment methods
HK40015952A
(en )
2020-09-04
Methods and compositions for the treatment of myelodysplastic syndrome
HK40057675A
(en )
2022-04-14
Methods of treating cytokine release syndrome
HK40062182A
(en )
2022-06-10
Method of treatment
HK40062407A
(en )
2022-06-10
Methods for the treatment of depression
HK40050425A
(en )
2021-12-24
Methods of treating substance abuse
HK40040493A
(en )
2021-07-30
Treatment of fragile x syndrome
HK40038038A
(en )
2021-06-18
Methods of treatment of hypertrigl yceridemia
HK40032171A
(en )
2021-03-19
Combination treatment of sarcoglycanopathies
HK40052938A
(en )
2022-01-28
Treatments